Dai Chihara

4.1k citations
128 papers · 2.1k indexed · h-index 25

Dai Chihara

120 papers receiving 2.1k citations

Peers

Dai Chihara
Comparison fields: 5 of 89
  • Pathology and Forensic Medicine 1.2k
  • Genetics 662
  • Oncology 932
  • Hematology 359
  • Neurology 352
Replace Kirit M. Ardeshna with:
Kirit M. Ardeshna United Kingdom
Jean Gabarre France
DY Mason United Kingdom
Mary Jo Lechowicz United States
Claire Dearden United Kingdom
Paul Fields United Kingdom
Keisei Kawa Japan
John M. Flexner United States
Lode J. Swinnen United States
Kosei Matsue Japan
Dai Chihara relative to Kirit M. Ardeshna United Kingdom Kirit M. Ardeshna's profile →
Citations per field
00.5×2.6×
Kirit M. Ardeshna · 1×
Citations per year

Countries citing papers authored by Dai Chihara

Since Specialization
Citations

This map shows the geographic impact of Dai Chihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Chihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Chihara more than expected).

Fields of papers citing papers by Dai Chihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Chihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Chihara. The network helps show where Dai Chihara may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dai Chihara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dai Chihara Line = papers co-authored together Dai Chihara links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20250
4 20250
5 20240
6 20241
7 20244
8 20242
9 20241
10 20240
11 20231
12 20236
13 20215
14 201914
15 201911
16 20171
17 201621
18 2015122
19 20142
20 201174

About Dai Chihara

Dai Chihara is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Hematology, having authored 128 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (88 papers), Viral-associated cancers and disorders (33 papers), Chronic Lymphocytic Leukemia Research (31 papers), CNS Lymphoma Diagnosis and Treatment (26 papers), T-cell and Retrovirus Studies (18 papers), CAR-T cell therapy research (14 papers), Acute Lymphoblastic Leukemia research (12 papers) and Cutaneous lymphoproliferative disorders research (7 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Genetics (662 citations), Oncology (932 citations), Hematology (359 citations) and Neurology (352 citations). Dai Chihara has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Hidemi Ito, Keitaro Matsuo, Tomohiro Matsuda, Yasuhiro Oki, Loretta J. Nastoupil, Akiko Shibata, Tomotaka Sobue, Nathan Fowler, Shigeo Nakamura and Lindsay M. Morton. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, Annals of Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026